A candid case study of a failed pharma startup deal — lessons on risk, relationships, and protecting a startup’s business.
Learn about the challenges of rare disease drug development and care and how digital health has the potential to revolutionize nearly every aspect.
A gap exists between pharma and digital health startup that prevents them from engaging in fruitful partnerships. What's going wrong?
What will 2020 and beyond bring for the digital health ecosystem?
Innovating in highly regulated industries can be challenging, but it is necessary. For innovation to flourish despite legal and regulatory obstacles, we must address innovation barriers head-on.
The ROI of digital health is more than just financial, it can take many other forms. Here are my top five.
2020 was not the year any of us expected, however in the world of digital health the growth of innovative solutions has been an unexpected silver lining.